Atea Pharmaceuticals Inc (AVIR)
R&D Expense Growth
1.80%
Fiscal year · Period ending:
AVIR R&D Expense Growth
Latest reported1.80%period ending
Latest reported1.80%period ending
AVIR FY R&D Growth (YoY) (0.00% → 1.80%)
Latest values, visible window
High-resolution chart · PNG
AVIR r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 1.804% | |
| 9.4533% | |
| 49.5373% | |
| -46.87% | |
| 339.747% | |
| 273.8741% | |
| 52.3596% | |
| 0% |